Zhejiang Zhenyuan Share Co Ltd (000705) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Zhejiang Zhenyuan Share Co Ltd ¥1.15, price ¥7.13, upside -83.9%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Zhejiang Zhenyuan Share Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ¥5.85 – ¥10.99 · fair‑value band ¥0.9500 – ¥1.44 · the ¥7.13 price screens above the ¥1.15 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Zhejiang Zhenyuan Share Co in your weekly email
Every Wednesday you see whether Zhejiang Zhenyuan Share Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Zhejiang Zhenyuan Share Co.,Ltd. engages in the manufacture and wholesale of pharmaceutical products in China and internationally.
Show more
Zhejiang Zhenyuan Share Co.,Ltd. engages in the manufacture and wholesale of pharmaceutical products in China and internationally. Its products include Chinese herbal medicines and slices, Chinese patent medicines, chemical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc. The company also provides pharmaceutical logistics, health services, etc.; and engages in the wholesale and retail of pharmaceutical products, pre-packaged food, and bulk food and dairy products. In addition, it sells its pharmaceutical products through online and offline channels. The company was founded in 1993 and is based in Shaoxing, China.
Stock analysis
Zhejiang Zhenyuan Share Co Ltd (000705) currently trades at ¥7.13, while our model-based Fair Value estimate is ¥1.15, 83.9% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of ¥3.96 per share, and 0 of the 14 models we run sit above the ¥7.13 price.
Bear case: the Earnings-Based group reads lowest at ¥0.3700, and 14 of the 14 models stay below the price. Evidence for this calculation is low.
Scenario range: ¥0.9500 (bear) to ¥1.44 (bull), the price of ¥7.13 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Zhejiang Zhenyuan Share Co Ltd reported revenue of 2.3B CNY in FY2025 versus 3.6B CNY in FY2021, a compound −10.9%/yr. Reported net income was 22.7M CNY in FY2025, compounding −26.4%/yr from FY2021.
Key figures
Market cap 2.4B CNY (≈ $356M) · P/S ratio 1.11 · EPS (TTM) ¥−0.1000 · Net margin 1.0% · Return on equity −1.8% · Return on assets (EBIT) 2.6% · Operating margin −2.6% · Revenue (TTM) 2.0B CNY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 31% below its 52-week high and 22% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at −84%, 000705 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (¥0.3700 to ¥5.81). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ¥0.9500Fair Value ¥1.15Bull ¥1.44
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.14/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−39.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−18.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.9%
Start year 2020 (pandemic). Over 10 years: +0.5% a year
Revenue growth 32 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−24.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−24.1%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−24.1% vs −5.5%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.3% → 1%
Compare Zhejiang Zhenyuan Share Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - General · 73 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score54 · Below median
Fair Value upside−83.9% · Bottom 25%
Profitability
Return on assets−0.8% · Bottom 25%
Net margin (TTM)−1.8% · Bottom 25%
Operating margin (TTM)−2.6% · Bottom 25%
Growth and dividend
Revenue growth−41.4% · Bottom 25%
Dividend yield (TTM)0.0% · Bottom 25%
Balance sheet
Debt / equity0.07× · Below median
Valuation Multiplesvs Drug Manufacturers - General median · lower = cheaper
P/B0.18× · Cheapest 25%
P/S (TTM)0.18× · Cheapest 25%
EV/EBITDA1.8× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 19
FUTURE (revenue growth)0· sector 33
PAST (return on equity)0· sector 41
HEALTH (low debt)97· sector 92
DIVIDEND (yield)0· sector 41
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Zhejiang Zhenyuan Share Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/000705
Frequently asked questions
Is Zhejiang Zhenyuan Share Co Ltd (000705) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥1.15 versus a price of ¥7.13, about −84% upside (overvalued).
What is the fair value of 000705?
Our model-based fair value for Zhejiang Zhenyuan Share Co Ltd is ¥1.15 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥7.13.
What is the quality score of 000705?
Zhejiang Zhenyuan Share Co Ltd has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Zhejiang Zhenyuan Share Co Ltd (000705)?
Our model-based price target is the fair value of ¥1.15 (as of Sep 24, 2026) from 14 valuation models. Cautious scenario ¥0.9500, optimistic scenario ¥1.44. It is a calculation from audited fundamentals, not an analyst target.
What is the Zhejiang Zhenyuan Share Co Ltd stock forecast for 2026?
Our models put fair value at ¥1.15, about −84% upside versus a price of ¥7.13 (overvalued). Cautious scenario ¥0.9500, optimistic scenario ¥1.44. The calculation is refreshed regularly with new filings.
What is the revenue of Zhejiang Zhenyuan Share Co Ltd (000705)?
Zhejiang Zhenyuan Share Co Ltd reported trailing-twelve-month revenue of about 2.0B CNY (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Zhejiang Zhenyuan Share Co Ltd (000705)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Zhejiang Zhenyuan Share Co Ltd it is ¥1.15 per share (as of Sep 24, 2026), against a price of ¥7.13. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Zhejiang Zhenyuan Share Co Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 000705 trades above its calculated fair value: price ¥7.13, fair value ¥1.15, a gap of about −84% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 000705?
No. The price is what the market pays today (¥7.13); the fair value is what the company's own numbers justify (¥1.15). For Zhejiang Zhenyuan Share Co Ltd the two are ¥5.98 per share apart. That gap is exactly why we show both numbers side by side.
How much is Zhejiang Zhenyuan Share Co Ltd worth?
The market values Zhejiang Zhenyuan Share Co Ltd at about 2.4B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥7.13; our models calculate a fair value of ¥1.15 per share.
What do the bullish and bearish scenarios say about 000705?
Our models span a range for Zhejiang Zhenyuan Share Co Ltd: cautious scenario ¥0.9500, base ¥1.15, optimistic ¥1.44 per share (as of Sep 24, 2026, price ¥7.13). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Zhejiang Zhenyuan Share Co Ltd (000705)?
Balance-sheet figures for Zhejiang Zhenyuan Share Co Ltd (as of Sep 24, 2026): return on equity −1.8%, debt of 0.07 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is 000705 from its 52-week high?
Zhejiang Zhenyuan Share Co Ltd trades at ¥7.13, about 31% below its 52-week high of ¥10.34 and 22% above the low of ¥5.85 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of ¥1.15 is for.
Which stocks are comparable to Zhejiang Zhenyuan Share Co Ltd?
From the same area (Healthcare) we also value Eli Lilly and Company, Johnson & Johnson,, AbbVie Inc, Roche Holding, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Zhejiang Zhenyuan Share Co Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price ¥7.13, calculated fair value ¥1.15 (−84%), Quality Score 54/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 000705 calculated?
We run Zhejiang Zhenyuan Share Co Ltd through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥1.15, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Zhejiang Zhenyuan Share Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Zhejiang Zhenyuan Share Co Ltd (000705)?
The closing price on Sep 30, 2026 was ¥7.13. Our model-based fair value is ¥1.15, about −84% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Zhejiang Zhenyuan Share Co Ltd right now?
The price sits above even our optimistic bull case (¥1.44). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Zhejiang Zhenyuan Share Co Ltd (000705) come from?
Earnings per share at Zhejiang Zhenyuan Share Co Ltd grew +3.7 % a year from 2013 to 2024. Broken into its drivers: revenue per share +7.2 %, EBIT margin −0.8 %, tax rate −1.2 %, residual (interest, one-offs) −1.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Zhejiang Zhenyuan Share Co Ltd
How large is the market capitalisation of Zhejiang Zhenyuan Share Co Ltd (000705)?
The market capitalisation of Zhejiang Zhenyuan Share Co Ltd is 2.4B CNY (≈ $356M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Zhejiang Zhenyuan Share Co Ltd (000705)?
The price-to-sales ratio of Zhejiang Zhenyuan Share Co Ltd is 1.11 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Zhejiang Zhenyuan Share Co Ltd (000705)?
Earnings per share at Zhejiang Zhenyuan Share Co Ltd are ¥−0.1000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Zhejiang Zhenyuan Share Co Ltd (000705)?
The net margin of Zhejiang Zhenyuan Share Co Ltd is 1.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Zhejiang Zhenyuan Share Co Ltd (000705)?
The return on equity (ROE) of Zhejiang Zhenyuan Share Co Ltd is −1.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Zhejiang Zhenyuan Share Co Ltd (000705)?
On an EBIT basis the return on assets of Zhejiang Zhenyuan Share Co Ltd is 2.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Zhejiang Zhenyuan Share Co Ltd (000705)?
The operating margin of Zhejiang Zhenyuan Share Co Ltd is −2.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Zhejiang Zhenyuan Share Co Ltd (000705)?
Revenue at Zhejiang Zhenyuan Share Co Ltd is growing −41.4% versus a year earlier (3y avg −18.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Zhejiang Zhenyuan Share Co Ltd (000705)?
Earnings per share at Zhejiang Zhenyuan Share Co Ltd are growing −14.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Zhejiang Zhenyuan Share Co Ltd (000705) generate?
The free cash flow of Zhejiang Zhenyuan Share Co Ltd is −146M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Zhejiang Zhenyuan Share Co Ltd (000705) hold?
Zhejiang Zhenyuan Share Co Ltd holds more cash than debt, 135M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Zhejiang Zhenyuan Share Co Ltd in the live analysis
One click puts Zhejiang Zhenyuan Share Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
